2024-04-012025-03-312025-03-31false06036754GLENDAIR DENTAL LIMITED2025-11-2186230falseiso4217:GBPxbrli:pure060367542024-03-31060367542025-03-31060367542024-04-012025-03-31060367542023-03-31060367542024-03-31060367542023-04-012024-03-3106036754bus:SmallEntities2024-04-012025-03-3106036754bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3106036754bus:FullAccounts2024-04-012025-03-3106036754bus:PrivateLimitedCompanyLtd2024-04-012025-03-3106036754core:WithinOneYear2025-03-3106036754core:AfterOneYear2025-03-3106036754core:WithinOneYear2024-03-3106036754core:AfterOneYear2024-03-3106036754core:ShareCapital2025-03-3106036754core:SharePremium2025-03-3106036754core:RevaluationReserve2025-03-3106036754core:OtherReservesSubtotal2025-03-3106036754core:RetainedEarningsAccumulatedLosses2025-03-3106036754core:ShareCapital2024-03-3106036754core:SharePremium2024-03-3106036754core:RevaluationReserve2024-03-3106036754core:OtherReservesSubtotal2024-03-3106036754core:RetainedEarningsAccumulatedLosses2024-03-3106036754core:LandBuildings2025-03-3106036754core:PlantMachinery2025-03-3106036754core:Vehicles2025-03-3106036754core:FurnitureFittings2025-03-3106036754core:OfficeEquipment2025-03-3106036754core:NetGoodwill2025-03-3106036754core:IntangibleAssetsOtherThanGoodwill2025-03-3106036754core:ListedExchangeTraded2025-03-3106036754core:UnlistedNon-exchangeTraded2025-03-3106036754core:LandBuildings2024-03-3106036754core:PlantMachinery2024-03-3106036754core:Vehicles2024-03-3106036754core:FurnitureFittings2024-03-3106036754core:OfficeEquipment2024-03-3106036754core:NetGoodwill2024-03-3106036754core:IntangibleAssetsOtherThanGoodwill2024-03-3106036754core:ListedExchangeTraded2024-03-3106036754core:UnlistedNon-exchangeTraded2024-03-3106036754core:LandBuildings2024-04-012025-03-3106036754core:PlantMachinery2024-04-012025-03-3106036754core:Vehicles2024-04-012025-03-3106036754core:FurnitureFittings2024-04-012025-03-3106036754core:OfficeEquipment2024-04-012025-03-3106036754core:NetGoodwill2024-04-012025-03-3106036754core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106036754core:ListedExchangeTraded2024-04-012025-03-3106036754core:UnlistedNon-exchangeTraded2024-04-012025-03-3106036754core:MoreThanFiveYears2024-04-012025-03-3106036754core:Non-currentFinancialInstruments2025-03-3106036754core:Non-currentFinancialInstruments2024-03-3106036754dpl:CostSales2024-04-012025-03-3106036754dpl:DistributionCosts2024-04-012025-03-3106036754core:LandBuildings2024-04-012025-03-3106036754core:PlantMachinery2024-04-012025-03-3106036754core:Vehicles2024-04-012025-03-3106036754core:FurnitureFittings2024-04-012025-03-3106036754core:OfficeEquipment2024-04-012025-03-3106036754dpl:AdministrativeExpenses2024-04-012025-03-3106036754core:NetGoodwill2024-04-012025-03-3106036754core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106036754dpl:GroupUndertakings2024-04-012025-03-3106036754dpl:ParticipatingInterests2024-04-012025-03-3106036754dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3106036754core:ListedExchangeTraded2024-04-012025-03-3106036754dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3106036754core:UnlistedNon-exchangeTraded2024-04-012025-03-3106036754dpl:CostSales2023-04-012024-03-3106036754dpl:DistributionCosts2023-04-012024-03-3106036754core:LandBuildings2023-04-012024-03-3106036754core:PlantMachinery2023-04-012024-03-3106036754core:Vehicles2023-04-012024-03-3106036754core:FurnitureFittings2023-04-012024-03-3106036754core:OfficeEquipment2023-04-012024-03-3106036754dpl:AdministrativeExpenses2023-04-012024-03-3106036754core:NetGoodwill2023-04-012024-03-3106036754core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106036754dpl:GroupUndertakings2023-04-012024-03-3106036754dpl:ParticipatingInterests2023-04-012024-03-3106036754dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3106036754core:ListedExchangeTraded2023-04-012024-03-3106036754dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3106036754core:UnlistedNon-exchangeTraded2023-04-012024-03-3106036754core:NetGoodwill2025-03-3106036754core:IntangibleAssetsOtherThanGoodwill2025-03-3106036754core:LandBuildings2025-03-3106036754core:PlantMachinery2025-03-3106036754core:Vehicles2025-03-3106036754core:FurnitureFittings2025-03-3106036754core:OfficeEquipment2025-03-3106036754core:AfterOneYear2025-03-3106036754core:WithinOneYear2025-03-3106036754core:ListedExchangeTraded2025-03-3106036754core:UnlistedNon-exchangeTraded2025-03-3106036754core:ShareCapital2025-03-3106036754core:SharePremium2025-03-3106036754core:RevaluationReserve2025-03-3106036754core:OtherReservesSubtotal2025-03-3106036754core:RetainedEarningsAccumulatedLosses2025-03-3106036754core:NetGoodwill2024-03-3106036754core:IntangibleAssetsOtherThanGoodwill2024-03-3106036754core:LandBuildings2024-03-3106036754core:PlantMachinery2024-03-3106036754core:Vehicles2024-03-3106036754core:FurnitureFittings2024-03-3106036754core:OfficeEquipment2024-03-3106036754core:AfterOneYear2024-03-3106036754core:WithinOneYear2024-03-3106036754core:ListedExchangeTraded2024-03-3106036754core:UnlistedNon-exchangeTraded2024-03-3106036754core:ShareCapital2024-03-3106036754core:SharePremium2024-03-3106036754core:RevaluationReserve2024-03-3106036754core:OtherReservesSubtotal2024-03-3106036754core:RetainedEarningsAccumulatedLosses2024-03-3106036754core:NetGoodwill2023-03-3106036754core:IntangibleAssetsOtherThanGoodwill2023-03-3106036754core:LandBuildings2023-03-3106036754core:PlantMachinery2023-03-3106036754core:Vehicles2023-03-3106036754core:FurnitureFittings2023-03-3106036754core:OfficeEquipment2023-03-3106036754core:AfterOneYear2023-03-3106036754core:WithinOneYear2023-03-3106036754core:ListedExchangeTraded2023-03-3106036754core:UnlistedNon-exchangeTraded2023-03-3106036754core:ShareCapital2023-03-3106036754core:SharePremium2023-03-3106036754core:RevaluationReserve2023-03-3106036754core:OtherReservesSubtotal2023-03-3106036754core:RetainedEarningsAccumulatedLosses2023-03-3106036754core:AfterOneYear2024-04-012025-03-3106036754core:WithinOneYear2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106036754core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106036754core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106036754core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3106036754core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3106036754core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3106036754bus:Director12024-04-012025-03-3106036754bus:Director22024-04-012025-03-3106036754core:FurnitureFittingsToolsEquipment2024-03-3106036754core:FurnitureFittingsToolsEquipment2024-04-012025-03-3106036754core:FurnitureFittingsToolsEquipment2025-03-31

GLENDAIR DENTAL LIMITED

Registered Number
06036754
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

GLENDAIR DENTAL LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

HARSTON, Beverley Jayne
LAMB, Matthew St John, Dr

Company Secretary

LAMB, Matthew St John, Dr

Registered Address

The Surgery
Limes Avenue
Alfreton
DE55 7DW

Registered Number

06036754 (England and Wales)
GLENDAIR DENTAL LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets5740,571785,736
740,571785,736
Current assets
Stocks612,84215,354
Debtors7866,70935,915
Cash at bank and on hand302,376580,735
1,181,927632,004
Creditors amounts falling due within one year8(364,362)(461,328)
Net current assets (liabilities)817,565170,676
Total assets less current liabilities1,558,136956,412
Creditors amounts falling due after one year9(290,031)(375,688)
Provisions for liabilities12(70,003)(66,951)
Net assets1,198,102513,773
Capital and reserves
Called up share capital10,00210,002
Profit and loss account1,188,100503,771
Shareholders' funds1,198,102513,773
The financial statements were approved and authorised for issue by the Board of Directors on 21 November 2025, and are signed on its behalf by:
HARSTON, Beverley Jayne
Director
LAMB, Matthew St John, Dr
Director

Registered Company No. 06036754
GLENDAIR DENTAL LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
Freehold building and improvements to property - 2% on cost No depreciation is charged on freehold land.

Reducing balance (%)
Plant and machinery25
Fixtures and fittings25
Vehicles25
Office Equipment25
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year2222
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24346,858346,858
At 31 March 25346,858346,858
Amortisation and impairment
At 01 April 24346,858346,858
At 31 March 25346,858346,858
Net book value
At 31 March 25--
At 31 March 24--
5.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

££££££
Cost or valuation
At 01 April 24644,555308,33360,252136,11135,4291,184,680
Additions-13,787--12,20425,991
At 31 March 25644,555322,12060,252136,11147,6331,210,671
Depreciation and impairment
At 01 April 2499,174161,89915,063105,23217,576398,944
Charge for year8,49537,67511,2967,7205,97071,156
At 31 March 25107,669199,57426,359112,95223,546470,100
Net book value
At 31 March 25536,886122,54633,89323,15924,087740,571
At 31 March 24545,381146,43445,18930,87917,853785,736
6.Stocks

2025

2024

££
Other stocks12,84215,354
Total12,84215,354
7.Debtors: amounts due within one year

2025

2024

££
Amounts owed by group undertakings6,8716,117
Other debtors840,5472,819
Prepayments and accrued income19,29126,979
Total866,70935,915
8.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables24,18642,169
Bank borrowings and overdrafts78,43667,771
Taxation and social security180,115260,994
Finance lease and HP contracts9,7989,890
Other creditors4,1791,876
Accrued liabilities and deferred income67,64878,628
Total364,362461,328
9.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts263,285337,733
Other creditors26,74637,955
Total290,031375,688
10.Secured creditors
The bank loan of £338,613 (2024: £405,000) is secured by following charges; The company has granted a standard security in favour of Barclays Security Trustee Limited over the property known as Glendair Dental Practice, Limes Avenue, Alfreton, DE55 7DW. The company has granted a floating charge in favour of Barclays Security Trustee Limited over all present and future undertakings, assets and property of the business.
11.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts26,74637,955
12.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)70,00366,951
Total70,00366,951
13.Related party transactions
Other debtors include an overdrawn directors' loan account balance of £435,752 of which £157,843 relates to Mrs B J Harston and £277,909 relates to Mr M S Lamb. Other debtors include balance of £402,876 (2024: £Nil) relating to Glendair Lettings Limited which is an associated company under common control of the directors. Amounts owed by/to group undertakings relates to the following: The company was owed £6,871 (2024: 6,117) by Glendair Finance Holdings Limited.
14.Exceptional items
Exceptional items of £18,775 relates to loan due to an associated company, Glendair Facial Aesthetics Limited written off during the year.
15.Controlling party
The ultimate controlling parties are Mrs B J Hartson and Mr M S Lamb by virtue of their shareholding in Glendair Finance Holdings Ltd, which is the parent company.